Clinical Trial Update: Study on Immunogenicity and Safety of a Meningococcal ACYW Conjugate Vaccine in Healthy Infants and Toddlers [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the immunogenicity and safety of a Meningococcal ACYW Conjugate Vaccine in healthy infants and toddlers has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• Meningococcal ACYW Conjugate Vaccine

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningococcal Immunisation, Healthy Volunteers | Phase 3 | Status: COMPLETED